Illumina Stock News

Sunny Isles Beach, Florida, May 1, 2023 — Today, Carl C. Icahn released the following open letter to the shareholders of Illumina, Inc. ( ILMN , Financial).

Illumina Inc. ILMN said Monday that activist investor Carl Icahn's board nominees are “unqualified,” urging shareholders to reject all three of Icahn's nominees and instead support its “highly q

#Morningstar #StockMarket #Investing Plus what the Federal Reserve meeting may mean for markets this week. Every Monday morning, Susan Dziubinski sits down with Morningstar Chief U.S. markets strategi

Activist investor Carl Icahn accused Illumina CEO Francis deSouza of trying to downplay the company's "decidedly mediocre" Q1 2023 results this week.

The U.S. government has sounded the alarm about a critical software vulnerability found in genomics giant Illumina's DNA sequencing devices, which hackers can exploit to modify or steal patients' sens

CEO Francis deSouza said San Diego-based Illumina can significantly expand the market for Grail's early cancer screening test.

Illumina's (ILMN) Q1 revenues decline year over year, reflecting the impact of Covid-19 monitoring headwinds and the transition of its high-throughput customers to NovaSeq X.

Illumina CEO Francis deSouza joins 'Squawk Box' to discuss Q1 earnings results, the company's Grail acquisition challenge, the future of DNA sequencing, and more.

While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare

Illumina, Inc. (ILMN) Q1 2023 Earnings Call Transcript.

Illumina (ILMN) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $1.07 per share a year ago.

The plans aim to reduce Illumina's annualized run rate expenses by more than $100 million starting later this year.

Illumina narrowly topped first-quarter forecasts Tuesday as its fight to retain its Grail subsidiary continues. ILMN stock dipped.

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Exelixis (EXEL) and Illumina (ILMN). But which of these two stocks is more attractive to value investors?

Sunny Isles Beach, Florida, April 24, 2023 — Today, Carl C. Icahn released the following open letter to the shareholders of Illumina, Inc. ( ILMN , Financial).